SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?


To: Mike M who wrote (2416)3/29/2000 11:09:00 AM
From: Hank  Respond to of 5582
 
"You can follow Hank's advice if you want but how would you know in which asylum to look for him when you want to kick his silly butt after the short goes sour?"

Hmmm. GUMM dips below $16 AGAIN. The second time in less than six months. Pretty strange for a stock that supposed to hit $60- $100 by the end of the year.

You're problem Mikey is that nobody every told you that in order to make money in the stock market you have to actually SELL your long positions when given the opportunity to realize a substantial profit. You were obviously too daft to sell at $30 and now you're doomed to watch any remaining potential profits decay day by day. What a loser.



To: Mike M who wrote (2416)3/29/2000 12:02:00 PM
From: pz  Read Replies (1) | Respond to of 5582
 
Just some questions while we watch GUMM fall to 13 or so.

1. Why is it that the company can't comment on the clinicals that we all know are supposed to be completed? Couldn't they at least give us a status? Or something, for pete's sake? A pessimistic person would read into this that the results were poor and that they are hiding the info. I know Zicam works, so I know this is not the case.

2. I know it's not the company's policy to put out news to stop the slide in the stock price, which makes it appear that they couldn't give a crap about it. Maybe at 13 they'll say something?

Just venting a bit.......

Paul